| # | Query | Results |
| S28 | S9 AND S26 AND S27 | 82 |
| S27 | S10 OR S11 OR S12 OR S13 OR S14 | 645 |
| S26 | S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 | 990,143 |
| S25 | TX allocat* random* | 4,464 |
| S24 | (MH "Quantitative Studies") | 13,814 |
| S23 | (MH "Placebos") | 9,427 |
| S22 | TX placebo* | 34,772 |
| S21 | TX random* allocat* | 4,464 |
| S20 | (MH "Random Assignment") | 39,802 |
| S19 | TX randomi* control* trial* | 93,467 |
| S18 | TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) | 789,912 |
| S17 | TX clinic* n1 trial* | 175,948 |
| S16 | PT Clinical trial | 78,685 |
| S15 | (MH "Clinical Trials+") | 192,364 |
| S14 | TX 17 beta hydroxy | 5 |
| S13 | TX (boltin or livial) | 18 |
| S12 | TX 17 alpha | 338 |
| S11 | TX 17 hydroxy* | 281 |
| S10 | TX (tibilone or tibolone) | 153 |
| S9 | S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 | 23,371 |
| S8 | TX climacteri* | 1,799 |
| S7 | TX (postmenopaus* or perimenopaus*) | 14,679 |
| S6 | TX menopaus* | 12,192 |
| S5 | TX hot flash* | 2,163 |
| S4 | TX hot flush* | 484 |
| S3 | TX vasomotor | 1,147 |
| S2 | (MM "Postmenopause") | 3,604 |
| S1 | (MM "Climacteric") OR (MM "Perimenopause") OR (MM "Perimenopausal Symptoms") OR (MM "Menopause+") OR (MM "Hot Flashes") | 9,562 |